Hydrocodone Bitartrate And Acetaminophen Tablet
NDC Package 43386-357-01
Package Information
Hydrocodone Bitartrate And Acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.Limitations of UseBecause of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS], reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia. This formulation utilizes a tablet delivery system. Marketed by Lupin Pharmaceuticals,inc., this product is identified by NDC 43386-357 and is authorized under FDA application ANDA206245.
Identification & Billing
- RxCUI: 856999 - HYDROcodone bitartrate 10 MG / acetaminophen 325 MG Oral Tablet
- RxCUI: 856999 - acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet
- RxCUI: 856999 - APAP 325 MG / hydrocodone bitartrate 10 MG Oral Tablet
- RxCUI: 857002 - HYDROcodone bitartrate 5 MG / acetaminophen 325 MG Oral Tablet
- RxCUI: 857002 - acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43386 - Lupin Pharmaceuticals,inc.
- 43386-357 - Hydrocodone Bitartrate And Acetaminophen
- 43386-357-01 - 100 TABLET in 1 BOTTLE
- 43386-357 - Hydrocodone Bitartrate And Acetaminophen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43386-357). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43386-357-01 identifies a specific commercial package of 100 tablet in 1 bottle of Hydrocodone Bitartrate And Acetaminophen, a human prescription drug labeled by Lupin Pharmaceuticals,inc.. This tablet is formulated for oral use and contains acetaminophen; hydrocodone bitartrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lupin Pharmaceuticals,inc. on December 01, 2016. The current certification is valid through December 31, 2026.
How is this Lupin Pharmaceuticals,inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43386035701. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.